&w=3840&q=100)
Tata AutoComp, Katcon form JV to make advanced composites for North America
Tata AutoComp, in a statement, said the venture will specialise in lightweight applications for passenger and commercial vehicles, agricultural tractors, off-road vehicles, and specialised non-automotive segments.
A global supplier to the automotive industry, Katcon Global specialises in exhaust systems, thermal insulation and advanced materials components. The company operates with 11 manufacturing facilities and five technology centres spread across eight countries.
The two companies already have an over-decade-long collaboration for exhaust systems and emission after-treatment solutions.
In the venture, Tata AutoComp said, it brings technological leadership and customer relationships, while Katcon contributes operational excellence, regulatory expertise, and strong local execution capabilities.
The latest joint venture is a significant step aligned with both companies' strategic vision to expand their global footprint and serve global customers through advanced, sustainable materials.
Also Read
"It is the first time we are entering a partnership where we are contributing the core technology, what we see as a reverse model compared to our previous alliances. Our composite division brings proprietary technology, including patented formulations and in-house capabilities for composite compounds and sheet manufacturing," said Arvind Goel, Vice Chairman of Tata AutoComp Systems Ltd.
"By combining Katcon's advanced composite technologies with Tata AutoComp's deep industry expertise, we are well-positioned to deliver innovative, lightweight solutions that address the evolving needs of the North American automotive market," said Carlos Turner, CEO, Katcon.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Deccan Herald
an hour ago
- Deccan Herald
Tamil Nadu's textile hubs caught unawares, pray for tariff reversal
As much as 40% of bed linens, towels, and kitchen linens exported from Coimbatore and Karur go to the US, while over 35 percent of knitwear exported from Tiruppur is destined for the North American nation.


Time of India
8 hours ago
- Time of India
Sun Pharmaceutical says it won't expand US manufacturing base amid tariff concerns
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel India's largest drug maker Sun Pharmaceutical has no plans to further expand its manufacturing base in the US even as potential reciprocal tariff remains a significant unknown that could disrupt the sector that operates on thin margins.'We have a significant footprint in the United States and at this time we have no plans to move further manufacturing to the US,' Richard Ashcroft, CEO of Sun Pharma's North American business said over an investor call on Shanghvi, chairman and MD, agreed the company's current manufacturing capacity in the US is good enough and there are no plans to add on manufacturing or expanding existing base in the US is being seen as one of the options for the Indian generic drug makers to offset tariff impact if it is imposed. Sun Pharma already has its manufacturing facilities in North to Shanghvi the pharma sector continues to be exempt from the US reciprocal tariff levy so far until the outcome of an ongoing investigation under Section 232 of the US Trade Expansion Act.'My understanding is that post 232 investigation report, the US government will decide on the next step. Till that time, I think pharma will continue to be exempt from basic tariff,' Shanghvi Wednesday, the US announced a 25% general tariff on Indian imports from August 1. Though the exact contours of the levy is not yet clear, industry experts said drug formulations and APIs are as of now excluded . A framework announced by the US in April had explicitly exempted Pharma on Thursday reported a 20% decline in its Apr-Jun consolidated net profit to Rs 2,278 crore. However, its revenue from operations rose 10% to Rs 13,786 crore led by volume growth and new product decline in net profit was mainly on account of a one-time exceptional charge of Rs 818 Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) for the first quarter stood at Rs 4,302 crore, up 19.2%, with the resulting EBITDA margin of 31.1% due to improvement in raw material cost, higher specialty sales and branded formulation business in product company's US formulation sales were at $473 million, accounting for over 29.3% of total consolidated sales during the quarter. Its formulation sales in India were at Rs 4,721 crore, up by 13.9%, accounting for 34.2% of total consolidated sales for the quarter."The overall growth reflects steady progress across all our markets. India continues to show strong momentum, contributing meaningfully to our performance,' said Shanghvi. 'The US launch of Leqselvi represents an important step forward. It augments our portfolio in dermatology and adds a growth engine," he July, Sun launched its much-awaited novel alopecia or anti-baldness drug Leqselvi in the US following an out-of-court settlement of a patent dispute with US-based Incyte plans in the weight-loss drug space, COO Aalok Shanghvi said the company will be in the first wave of GLP1 launch in India. 'We are working in that direction so that we come first to the market,' he said.

Time of India
10 hours ago
- Time of India
Trump postpones higher Mexico tariff for 90 days
US President Donald Trump said Thursday he would hold off a planned tariff hike on Mexican products and instead keep duties at existing levels for 90 days after speaking with his counterpart Claudia Sheinbaum. "We have agreed to extend, for a 90 Day period, the exact same Deal as we had for the last short period of time," Trump wrote in a Truth Social post. The country currently faces a 25 percent US tariff for goods not entering under a North American trade pact . by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Indonesia: Bathroom Remodeling Trends in 2025 May Surprise You Bathroom Remodeling | Search Ads Search Now Undo